Welcome!

News Feed Item

Molecular Diagnostics in Cancer Testing

DUBLIN, April 9, 2014 /PRNewswire/ --

Dublin - Research and Markets (http://www.researchandmarkets.com/research/k3xnm6/molecular) has announced the addition of the "Molecular Diagnostics in Cancer Testing" report to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769 )


Molecular diagnostics is a rapidly-advancing area of research and medicine, with new technologies and applications being continually added. The technologies that come under the umbrella of molecular diagnostics include first-generation amplification, DNA probes, fluorescent in-situ hybridization (FISH), second-generation biochips and microfluidics, next-generation signal detection, biosensors and molecular labels, and gene expression profiling using microarrays.

These technologies are improving the discovery of therapeutic molecules for cancer, the screening, diagnosis and classification of cancer patients, and the optimization of drug therapy. This report describes the specific segment of the in vitro diagnostics (IVD) market known as molecular diagnostics (MD), with a specialization in the MD tests for cancer. In the current medical diagnostics market, molecular diagnostics for cancer testing offers one of the brightest areas for growth and innovation.

The confluence of breakthroughs in genomics, proteomics, and the development of microarray devices to measure analytes in the blood and various body tissues, has led to this revolutionary market segment offering the power of advanced analytical techniques to the diagnosis and treatment of cancer. This report analyzes the size and growth of the molecular diagnostics market in its applications for cancer detection and therapy, examining the factors that influence the various market segments and the dollar volume of sales, both in the United States and worldwide.


Key Topics Covered:

1. Overview

2. Introduction to Molecular Diagnostics

3. Cancer Diagnostics Molecular Testing Market

4. Molecular Diagnostic Tests for Cancer
4.1 Cancer Diagnostic Tests
4.2 Breast Cancer
4.3 Colorectal Cancer Molecular Diagnostics Market
4.4 Prostate Cancer Molecular Diagnostics Market
4.5 Other Cancer Molecular Diagnostic Markets
4.6 Molecular Diagnostic Screening Test for Cancer
4.7 Companion Diagnostic Tests for Cancer Therapeutics

5. Business
5.1 Technology and Market Trends
5.2 M&A Activity
5.3 Partnerships
5.4 Competitive Analysis
5.5 SWOT Comparison of Business Models for Cancer Diagnostic Testing
5.6 Intellectual Property Rights

6. Reimbursement and Billing
6.1 Overview
6.2 Trends in Reimbursement Practice
6.3 Breast Cancer Tests
6.4 Colon Cancer Tests
6.5 Trends in Patient Care and Reimbursement
6.6 Revenue Threats
6.7 Billing

7. Government Regulation
7.1 U.S. Food and Drug Administration
7.2 CLIA Regulations
7.3 Clinical Laboratory Improvement Act
7.4 State Licensing for Service Laboratories
7.5 FDA Treatment of Multivariate Index Assays
7.6 510(k) Clearance
7.7 Pre-Market Approval
7.8 ASRs
7.9 What Regulatory Guidance is Needed for Companion Biomarkers?
7.10 U.S. Patent and Trademark Office
7.11 IRB Approval in Clinical Trials
7.12 Oncology Biomarkers Qualification Initiative Project
7.13 FDA Clearance Picture for Insight Dx, MammaPrint, and Oncotype DX
7.14 FDA Packaging Requirements for Erbitux
7.15 Microarray Quality Control
7.16 CAP Evidence-based Recommendations to Improve the Accuracy of ER and PR Testing
7.17 ER and PR Proficiency Testing

8. Business Decisions Using Molecular Diagnostic Tests in Cancer Test Development

9. Company Profiles


Companies Mentioned:

  • Agendia
  • ArcticDx, Inc
  • Biodesix
  • Cancer Genetics, Inc
  • Clarient, Inc (GE Healthcare)
  • CombiMatrix Corporation
  • Epigenomics
  • Exact Sciences Corporation
  • Exagen Diagnostics, Inc
  • Exiqon
  • Ferrer inCode
  • Genomic Health, Inc
  • Genoptix, Inc
  • InterGenetics, Inc
  • LabCorp
  • Myriad Genetics, Inc
  • Nanostring
  • Neogenomics
  • Nuvera Biosciences
  • Orion Genomics
  • QIAGEN NV
  • Rosetta Genomics Ltd
  • SABiosciences Corporation (Qiagen)
  • Seegene
  • Sequenom, Inc
  • Source MDx
  • Targeted Molecular Diagnostics
  • bioTheranostics (AviaraDx)



For more information visit http://www.researchandmarkets.com/research/k3xnm6/molecular


Media Contact: Laura Wood , +353-1-481-1716, [email protected]

SOURCE Research and Markets

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
SYS-CON Events announced today that Golden Gate University will exhibit at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Since 1901, non-profit Golden Gate University (GGU) has been helping adults achieve their professional goals by providing high quality, practice-based undergraduate and graduate educational programs in law, taxation, business and related professions. Many of its courses are taug...
@DevOpsSummit at Cloud Expo taking place Oct 31 - Nov 2, 2017, at the Santa Clara Convention Center, Santa Clara, CA, is co-located with the 21st International Cloud Expo and will feature technical sessions from a rock star conference faculty and the leading industry players in the world. The widespread success of cloud computing is driving the DevOps revolution in enterprise IT. Now as never before, development teams must communicate and collaborate in a dynamic, 24/7/365 environment. There is ...
The question before companies today is not whether to become intelligent, it’s a question of how and how fast. The key is to adopt and deploy an intelligent application strategy while simultaneously preparing to scale that intelligence. In her session at 21st Cloud Expo, Sangeeta Chakraborty, Chief Customer Officer at Ayasdi, will provide a tactical framework to become a truly intelligent enterprise, including how to identify the right applications for AI, how to build a Center of Excellence to...
DevOps at Cloud Expo, taking place October 31 - November 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA, is co-located with 21st Cloud Expo and will feature technical sessions from a rock star conference faculty and the leading industry players in the world. The widespread success of cloud computing is driving the DevOps revolution in enterprise IT. Now as never before, development teams must communicate and collaborate in a dynamic, 24/7/365 environment. There is no time to w...
"We provide IoT solutions. We provide the most compatible solutions for many applications. Our solutions are industry agnostic and also protocol agnostic," explained Richard Han, Head of Sales and Marketing and Engineering at Systena America, in this SYS-CON.tv interview at @ThingsExpo, held June 6-8, 2017, at the Javits Center in New York City, NY.
Given the popularity of the containers, further investment in the telco/cable industry is needed to transition existing VM-based solutions to containerized cloud native deployments. The networking architecture of the solution isolates the network traffic into different network planes (e.g., management, control, and media). This naturally makes support for multiple interfaces in container orchestration engines an indispensable requirement.
SYS-CON Events announced today that DXWorldExpo has been named “Global Sponsor” of SYS-CON's 21st International Cloud Expo, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Digital Transformation is the key issue driving the global enterprise IT business. Digital Transformation is most prominent among Global 2000 enterprises and government institutions.
21st International Cloud Expo, taking place October 31 - November 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA, will feature technical sessions from a rock star conference faculty and the leading industry players in the world. Cloud computing is now being embraced by a majority of enterprises of all sizes. Yesterday's debate about public vs. private has transformed into the reality of hybrid cloud: a recent survey shows that 74% of enterprises have a hybrid cloud strategy. Me...
yperConvergence came to market with the objective of being simple, flexible and to help drive down operating expenses. It reduced the footprint by bundling the compute/storage/network into one box. This brought a new set of challenges as the HyperConverged vendors are very focused on their own proprietary building blocks. If you want to scale in a certain way, let’s say you identified a need for more storage and want to add a device that is not sold by the HyperConverged vendor, forget about it....
With Cloud Foundry you can easily deploy and use apps utilizing websocket technology, but not everybody realizes that scaling them out is not that trivial. In his session at 21st Cloud Expo, Roman Swoszowski, CTO and VP, Cloud Foundry Services, at Grape Up, will show you an example of how to deal with this issue. He will demonstrate a cloud-native Spring Boot app running in Cloud Foundry and communicating with clients over websocket protocol that can be easily scaled horizontally and coordinate...
In his session at 20th Cloud Expo, Scott Davis, CTO of Embotics, discussed how automation can provide the dynamic management required to cost-effectively deliver microservices and container solutions at scale. He also discussed how flexible automation is the key to effectively bridging and seamlessly coordinating both IT and developer needs for component orchestration across disparate clouds – an increasingly important requirement at today’s multi-cloud enterprise.
Any startup has to have a clear go –to-market strategy from the beginning. Similarly, any data science project has to have a go to production strategy from its first days, so it could go beyond proof-of-concept. Machine learning and artificial intelligence in production would result in hundreds of training pipelines and machine learning models that are continuously revised by teams of data scientists and seamlessly connected with web applications for tenants and users.
Vulnerability management is vital for large companies that need to secure containers across thousands of hosts, but many struggle to understand how exposed they are when they discover a new high security vulnerability. In his session at 21st Cloud Expo, John Morello, CTO of Twistlock, will address this pressing concern by introducing the concept of the “Vulnerability Risk Tree API,” which brings all the data together in a simple REST endpoint, allowing companies to easily grasp the severity of t...
Recently, WebRTC has a lot of eyes from market. The use cases of WebRTC are expanding - video chat, online education, online health care etc. Not only for human-to-human communication, but also IoT use cases such as machine to human use cases can be seen recently. One of the typical use-case is remote camera monitoring. With WebRTC, people can have interoperability and flexibility for deploying monitoring service. However, the benefit of WebRTC for IoT is not only its convenience and interopera...
IT organizations are moving to the cloud in hopes to approve efficiency, increase agility and save money. Migrating workloads might seem like a simple task, but what many businesses don’t realize is that application migration criteria differs across organizations, making it difficult for architects to arrive at an accurate TCO number. In his session at 21st Cloud Expo, Joe Kinsella, CTO of CloudHealth Technologies, will offer a systematic approach to understanding the TCO of a cloud application...